Our results suggested the possibility that ACSM3 attenuated the expression of cell proliferation or metastasis-related proteins by the inhibition of the Integrin β1/AKT signaling pathway in ovarian cancer. The gene discussed is ACSM3; the disease is ovarian carcinoma.